Online citations, reference lists, and bibliographies.
← Back to Search

Effects Of Ramipril On Endothelial Function And The Expression Of Proinflammatory Cytokines And Adhesion Molecules In Young Normotensive Subjects With Successfully Repaired Coarctation Of Aorta: A Randomized Cross-over Study.

S. Brili, D. Tousoulis, C. Antoniades, C. Vasiliadou, M. Karali, N. Papageorgiou, N. Ioakeimidis, K. Marinou, Elli Stefanadi, C. Stefanadis
Published 2008 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
OBJECTIVES The purpose of this study was to evaluate the effect of ramipril on endothelial function and inflammatory process in a group of normotensive subjects with successfully repaired coarctation of the aorta (SCR). BACKGROUND Subjects with SCR experience higher long-term cardiovascular risk as a result of the relapse of arterial hypertension or owing to nonreversible structural changes in the pre-coarctation arterial tree. These subjects experience endothelial dysfunction in the right forearm and appear to have elevated levels of proatherogenic inflammatory markers, even in the absence of arterial hypertension. METHODS Twenty young individuals age 27.3 +/- 2.4 years old with SCR 13.9 +/- 2.2 years previously, received ramipril 5 mg/day for 4 weeks in a randomized, cross-over, controlled trial. Endothelial function was evaluated in the right forearm by gauge-strain plethysmography, and serum levels of interleukin (IL)-1b, IL-6, soluble CD40 ligand (sCD40L), and soluble vascular cell adhesion molecule (sVCAM)-1 were determined by enzyme-linked immunosorbent assay. RESULTS Ramipril improved endothelial function (p < 0.001) and decreased the expression of proinflammatory cytokine IL-6 (p < 0.05) and sCD40L (p < 0.01). Furthermore, ramipril decreased serum levels of sVCAM-1 (p < 0.01) but failed to affect serum levels of C-reactive protein. These effects were independent of blood pressure lowering. CONCLUSIONS Ramipril reversed the impaired endothelial function and decreased the expression of proinflammatory cytokine IL-6, sCD40L, and adhesion molecules in normotensive subjects with SCR. These findings imply that ramipril treatment may have antiatherogenic effects in subjects with SCR, even in the absence of arterial hypertension.
This paper references
10.1016/0002-8703(47)90002-1
Coarctation of the aorta; a review of 104 autopsied cases of the adult type, 2 years of age or older.
G. H. Reifenstein (1947)
10.1161/01.CIR.66.3.513
Preoperative and Postoperative Renin Levels in Coarctation of the Aorta
F. Parker (1982)
10.1161/01.CIR.65.6.1060
Different reactivity and structure of the prestenotic and poststenotic aorta in human coarctation. Implications for baroreceptor function.
J. Sehested (1982)
10.1161/01.CIR.71.3.495
Increased forearm vascular reactivity in patients with hypertension after repair of coarctation.
S. Gidding (1985)
10.1056/NEJM198505093121904
Therapeutic effect of propranolol on paradoxical hypertension after repair of coarctation of the aorta.
S. Gidding (1985)
10.1016/0002-8703(87)90930-6
Postoperative hypertension after repair of coarctation of aorta in children: protective effect of propranolol?
F. Leenen (1987)
10.1161/01.CIR.80.4.840
Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction.
M. Cohen (1989)
10.1016/0002-8703(92)90815-D
Increased stiffness and persistent narrowing of the aorta after successful repair of coarctation of the aorta: relationship to left ventricular mass and blood pressure at rest and with exercise.
C. Ong (1992)
10.1161/01.CIR.89.4.1745
Arterial reactivity is significantly impaired in normotensive young adults after successful repair of aortic coarctation in childhood.
H. Gardiner (1994)
10.1016/S0002-8703(97)70111-X
Intravascular ultrasound assessment of regional aortic wall stiffness, distensibility, and compliance in patients with coarctation of the aorta.
J. Xu (1997)
10.1016/S0735-1097(98)80091-0
Aortic elastic properties in patients with repaired coarctation of aorta.
S. Brili (1998)
10.1152/ajpheart.1998.274.2.H539
Selective large coronary endothelial dysfunction in conscious dogs with chronic coronary pressure overload.
B. Ghaleh (1998)
10.1016/S0895-7061(99)00103-X
The renin-angiotensin-aldosterone system: a specific target for hypertension management.
M. Weir (1999)
10.1161/01.HYP.34.4.720
State-of-the-Art lecture: influence of exercise training on neurogenic control of blood pressure in spontaneously hypertensive rats.
E. Krieger (1999)
10.1161/01.HYP.34.4.987
State-of-the-Art lecture. Statins and blockers of the renin-angiotensin system: vascular protection beyond their primary mode of action.
A. Faggiotto (1999)
10.1016/S0735-1097(00)01138-4
Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis.
S. Navalkar (2001)
10.1161/hc4401.099447
Soluble CD40L and Cardiovascular Risk in Women
Uwe Schönbeck (2001)
10.1161/HC37T1.094900
Vascular dysfunction after repair of coarctation of the aorta: Impact of Early Surgery
M. de Divitiis (2001)
10.1161/HY09T1.095393
Chronic AT1 Receptor Blockade Alters Autonomic Balance and Sympathetic Responses in Hypertension
S. M. Bezerra (2001)
Chronic AT ( 1 ) receptor blockade alters autonomic balance and sympathetic responses in
SM Bezerra (2001)
10.1136/HEART.88.2.113
Survivors of coarctation repair: fixed but not cured
D. Celermajer (2002)
10.1016/S0735-1097(02)01976-9
Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women.
M. Modena (2002)
10.1161/01.ATV.0000021412.56621.A2
Vascular inflammation and the renin-angiotensin system.
A. Brasier (2002)
Treating the diabetic patient: appropriate care for glycemic control and cardiovascular disease risk factors.
S. Zarich (2003)
10.1016/J.ACCREVIEW.2004.02.025
C-reactive protein and the risk of developing hypertension.
H. Sesso (2003)
10.1016/J.ACCREVIEW.2004.12.159
Late systemic hypertension and aortic arch geometry after successful repair of coarctation of the aorta.
P. Ou (2004)
10.1136/hrt.2003.032847
Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques
D. Tousoulis (2005)
10.1093/EURHEARTJ/EHI037
Predicting the risk of early atherosclerotic disease development in children after repair of aortic coarctation.
A. A. Meyer (2005)
10.1016/J.NUMECD.2005.08.002
Arterial hypertension and cardiovascular prognosis after successful repair of aortic coarctation: a clinical model for the study of vascular function.
M. de Divitiis (2005)
10.1016/J.AMJHYPER.2005.05.034
Hypertension induced by aortic coarctation above the renal arteries is associated with immune cell infiltration of the kidneys.
B. Rodriguez-Iturbe (2005)
10.1016/J.ATHEROSCLEROSISSUP.2005.02.005
Markers of inflammation and their clinical significance.
C. Ballantyne (2005)
10.1161/01.HYP.0000153321.13792.b9
Angiotensin II and the Endothelium: Diverse Signals and Effects
T. Watanabe (2005)
10.1016/J.ATHEROSCLEROSIS.2005.01.030
Evidence of vascular dysfunction in young patients with successfully repaired coarctation of aorta.
S. Brili (2005)
10.1016/S0140-6736(06)69201-5
Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials
G. Dagenais (2006)
10.1161/CIRCULATIONAHA.106.174375
Clinical stress testing in the pediatric age group: a statement from the American Heart Association Council on Cardiovascular Disease in the Young, Committee on Atherosclerosis, Hypertension, and Obesity in Youth.
S. Paridon (2006)
10.1016/J.AMJCARD.2006.01.059
Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease.
C. Ferrario (2006)
10.1016/J.CYTOGFR.2006.04.003
Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside.
D. Tousoulis (2006)
10.1210/ME.2004-0536
Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II.
L. Hunyady (2006)
10.1016/J.AMJCARD.2006.12.049
Aortic arch geometry and exercise-induced hypertension in aortic coarctation.
E. De Caro (2007)
10.1136/hrt.2006.088211
Assessing inflammatory status in cardiovascular disease
D. Tousoulis (2007)



This paper is referenced by
10.17116/kardio202013031258
Aortic arch atresia in an 11-year-old patient
I. Soynov (2020)
10.1007/s00246-020-02320-3
Right Ventricular Strain Impairment in Adults and Adolescents with Repaired Aortic Coarctation
F. Labombarda (2020)
10.1016/j.ccl.2020.04.003
Aortic Coarctation.
Yuli Y. Kim (2020)
10.1016/j.amjcard.2018.10.017
Subclinical Burden of Coronary Artery Calcium in Patients With Coarctation of the Aorta.
Yamini Krishnamurthy (2019)
10.1007/s11936-019-0790-8
The Demystification of Secondary Hypertension: Diagnostic Strategies and Treatment Algorithms
J. Hirsch (2019)
10.1007/s11906-019-1003-2
Pro-inflammatory Cytokines and Resistant Hypertension: Potential for Novel Treatments?
M. Pioli (2019)
10.1161/CIRCIMAGING.117.007002
18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomographic Imaging Detects Aortic Wall Inflammation in Patients With Repaired Coarctation of Aorta
S. Brili (2018)
10.1007/978-3-319-31107-4_36
Pharmacologic Treatment of Pediatric Hypertension
M. Ferguson (2018)
10.1007/s00246-017-1739-x
Hypertension in Coarctation of the Aorta: Challenges in Diagnosis in Children
T. Vigneswaran (2017)
10.1161/CIR.0000000000000535
Diagnosis and Management of Noncardiac Complications in Adults With Congenital Heart Disease: A Scientific Statement From the American Heart Association.
G. Lui (2017)
10.1016/j.hjc.2017.01.016
A case of aortic arch coarctation, bicuspid aortic valve and aortic sinus aneurysm in an adult with moderate hypertension.
C. Chrysohoou (2017)
Diagnosis and Management of Noncardiac Complications in Adults With Congenital Heart Disease
G. Lui (2017)
10.1016/j.ijcard.2016.01.168
Impairment of arterial elastic properties and elevated circulating levels of transforming growth factor-beta in subjects with repaired coarctation of aorta.
S. Brili (2016)
10.1017/S1047951116001748
Primary-care management of patients with coarctation of the aorta*
Jeffrey R Boris (2016)
10.14740/jocmr2178e
Effect of Atorvastatin and Pioglitazone on Plasma Levels of Adhesion Molecules in Non-Diabetic Patients With Hypertension or Stable Angina or Both
Vishwanath Pattan (2015)
Estudo da integridade arterial em pacientes com coarctação da aorta, antes e após aortoplastia com implante de stent
J. Assef (2015)
10.3109/08037051.2014.940710
Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers
N. Barbaro (2015)
10.1007/s11906-014-0421-4
Late Hypertension in Patients with Repaired Aortic Coarctation
J. O'Sullivan (2014)
10.1016/j.hfc.2013.09.015
Heart failure caused by congenital left-sided lesions.
E. Krieger (2014)
10.1007/978-1-4471-5198-2_26
Arterial Stiffness and Risk in Various Cardiovascular Diseases
C. Vlachopoulos (2014)
10.1136/heartjnl-2014-305739
Endothelial function in contemporary patients with repaired coarctation of aorta
R. Radke (2014)
Aortic coarctation: late complications and treatment strategies
P. Luijendijk (2014)
10.2174/1573406410666140318111328
Inflammation markers in essential hypertension.
D. Tsounis (2014)
10.1016/j.ijcard.2012.09.084
Hypertension after repair of aortic coarctation--a systematic review.
C. Canniffe (2013)
10.1016/j.ijcard.2012.03.025
Flow mediated dilation and carotid intima media thickness: clinical markers or just research tools?
D. Tousoulis (2013)
10.1007/s00467-013-2510-z
Rational use of antihypertensive medications in children
M. Ferguson (2013)
10.1016/B978-1-4557-0101-8.00042-4
Chapter 42 – Care for Adults with Congenital Heart Disease
Michael J. Landzberg (2013)
10.1152/ajpheart.00420.2012
Altered hemodynamics, endothelial function, and protein expression occur with aortic coarctation and persist after repair.
A. Menon (2012)
10.1016/j.pharmthera.2012.05.004
Novel therapeutic strategies in the management of arterial hypertension.
D. Tousoulis (2012)
10.1016/j.ijcard.2011.12.087
Genetic polymorphism M235T of angiotensinogen: effects on endothelial function and arterial stiffness in hypertensives.
D. Tousoulis (2012)
10.1016/j.vph.2011.12.007
Vascular effects of glycoprotein130 ligands--part II: biomarkers and therapeutic targets.
S. Demyanets (2012)
Quantifying the impact of altered hemodynamics and vascular biomechanics to changes in structure and function in native and corrected aortic coarctation
A. Menon (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar